Furthermore, higher expression of XRCC4 was significantly linked to worse PFS and OS for all ovarian carcinoma women (PFS: HR=1.41 (1.22-1.62), OS: HR=1.56 (1.36-1.8), P=0.0000, P=0.0000). Here, XRCC4 is linked to ovarian carcinoma.